How to treat and manage covid19 in SCD patients

How to treat and manage covid19 in SCD patients

Bibliographic Details
Main Authors:	N. Verdiyeva, T. Ibrahimova, A. Nasibova, V. Huseynov
Format:	Article
Language:	English
Published:	Elsevier 2020-10-01
Series:	Hematology, Transfusion and Cell Therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2531137920302686

Similar Items

P110: CLINICAL CHARACTERISTICS OF COVID-19 IN SICKLE CELL DISEASE (SCD) PATIENTS
by: H Malhan, et al.
Published: (2022-01-01)

Increased Serum Levels of sCD14 and sCD163 Indicate a Preponderant Role for Monocytes in COVID-19 Immunopathology
by: Jose Gómez-Rial, et al.
Published: (2020-09-01)

P1480: SPLENIC SEQUESTRATION IS MORE COMMON IN SCD-S/Β0-THAL THAN IN SCD-S/S PATIENTS: RESULTS FROM THE GERMAN SCD REGISTRY
by: P. Allard, et al.
Published: (2022-06-01)

How the population of the Republic of Azerbaijan is ageing: causes and potential for social and economic development
by: Nailya Verdiyeva
Published: (2019-09-01)

Sums of SCD sets and their applications to SCD operators and narrow operators
by: Kadets Vladimir, et al.
Published: (2010-02-01)

Downregulation of sCD40 and sCTLA4 in Recovered COVID-19 Patients with Comorbidities
by: Gwendolyne Méndez-Frausto, et al.
Published: (2022-09-01)

sCD163, sCD28, sCD80, and sCTLA-4 as soluble marker candidates for detecting immunosenescence
by: Andrea Aprilia, et al.
Published: (2024-01-01)

SCD14-ST and New Generation Inflammatory Biomarkers in the Prediction of COVID-19 Outcome
by: Emanuela Galliera, et al.
Published: (2022-06-01)

PRELIMINARY STUDY OF SCD14 AND SCD163 AS PREDICTORS OF DISEASE SEVERITY AND ICU ADMISSION IN COVID-19: RELATION TO HEMATOLOGICAL PARAMETERS, BLOOD MORPHOLOGICAL CHANGES AND INFLAMMATORY BIOMARKERS
by: hend Attia
Published: (2023-08-01)

Role of Tocilizumab in Down Regulating sCD163 Plasmatic Levels in a Cohort of COVID-19 Patients
by: Raffaella Marocco, et al.
Published: (2022-04-01)

Persistent high plasma levels of sCD163 and sCD14 in adult patients with measles virus infection.
by: Claudia Mascia, et al.
Published: (2018-01-01)

Risk of classical Kaposi sarcoma by plasma levels of Epstein-Barr virus antibodies, sCD26, sCD23 and sCD30
by: Viviano Enza, et al.
Published: (2010-10-01)

5613426 LOW CHRONIC INFLAMMATION IN SCD
by: M.R. Rolli, et al.
Published: (2023-04-01)

HBH DISEASE AND SYSTEMIC LUPUS ERYTHEMATOSUS
by: Valeh Huseynov, et al.
Published: (2022-10-01)

The Role of Hydroxyurea on Growth in Children with SCD
by: Zahrah Mohammed Alkashi
Published: (2023-01-01)

“Role of kidney function and concentrations of BAFF, sPD-L1 and sCD25 on mortality in hospitalized patients with COVID-19”
by: Ladan Mansouri, et al.
Published: (2022-09-01)

The factor of the risk and risk management In information security
by: A. N. Ibrahimova
Published: (2021-12-01)

The factor of the risk and risk management In information security
by: A. N. Ibrahimova
Published: (2021-12-01)

Evaluating the Roles of sCD14 and sCD14-ST in Diagnosing COPD and Predicting an Acute Exacerbation of COPD
by: Rui Zhang, et al.
Published: (2022-06-01)

Neurological events and abnormalities in SCD cohort in Tanzania
by: Makani, J, et al.
Published: (2011)

THE CONTENTS OF SCD40 AND INDICATORS OF DAMAGED ENDOTHELIUM IN PATIENTS WITH CHRONIC KIDNEY DISEASE
by: I. I. Topchii, et al.
Published: (2017-12-01)

BACE1 and SCD1 are associated with neurodegeneration
by: Ferley A. Bedoya-Guzmán, et al.
Published: (2023-09-01)

SCD1, autophagy and cancer: implications for therapy
by: Francesca Ascenzi, et al.
Published: (2021-08-01)

SCD following myocardial infarction - Predicting the unpredictable
by: B.Hygriv Rao
Published: (2021-03-01)

rTMS regulates homotopic functional connectivity in the SCD and MCI patients
by: Honglin Ge, et al.
Published: (2023-11-01)

Outcome of Hydroxyurea Use in SCD and Evaluation of Patients’ Perception and Experience in Nigeria
by: Reuben Ikechukwu Chianumba, et al.
Published: (2022-03-01)

How to Treat COVID-19 Patients at Home in the Italian Context: An Expert Opinion
by: Davide Roberto Donno, et al.
Published: (2021-03-01)

How we treat patients with brain tumour during the COVID-19 pandemic
by: Mariano Provencio, et al.
Published: (2019-05-01)

Prospects for the application of active learning methods in modern education
by: Tunzala Verdiyeva
Published: (2021-08-01)

“ANNE” KAVRAMININ KULLANILDIĞI RUS VE AZERBAYCAN ATASÖZLERİNİN KARŞILAŞTIRMALI DEĞERLENDİRİLMESİ
by: Elnura Verdiyeva
Published: (2021-06-01)

THE INFLUENCE OF CETIRIZINE ON THE CONCENTRATION OF sCD14 IN BLOOD OF THE CHILDREN WITH ATOPIC DERMATITIS
by: E.S. Nisheva, et al.
Published: (2006-03-01)

THE INFLUENCE OF CETIRIZINE ON THE CONCENTRATION OF sCD14 IN BLOOD OF THE CHILDREN WITH ATOPIC DERMATITIS
by: E.S. Nisheva, et al.
Published: (2006-01-01)

PB2214: SCD POPULATION SURVEY IN ALBANIA, A PROSPECTIVE NON-INTERVENTIONAL MULTI-CENTER STUDY EVALUATING DISEASE AND PATIENTS CHARACTERISTICS OF SICKLE CELL DISEASE IN ALBANIAN SCD POPULATION
by: A. Cili, et al.
Published: (2022-06-01)

SCD: A Stacked Carton Dataset for Detection and Segmentation
by: Jinrong Yang, et al.
Published: (2022-05-01)

Fostering Creative Confidence with SCD in Interaction Design Education
by: Laurens Boer, et al.
Published: (2021-12-01)

Proposta do Serviço de Comunicações Digitais – SCD
by: Jussara Costa Melo
Published: (2013-05-01)

Biomarkers in Forensic Diagnosis of Sudden Cardiac Death (SCD)
by: Saikat Das, et al.
Published: (2019-05-01)

Scd1 and monounsaturated lipids are required for autophagy and survival of adipocytes
by: Hiroyuki Mori, et al.
Published: (2024-05-01)

Postoperative serum levels of sCD26 for surveillance in colorectal cancer patients.
by: Loretta De Chiara, et al.
Published: (2014-01-01)

Interaction between cytokines and sCD40L in patients with stable and unstable coronary syndromes.
by: Tousoulis, D, et al.
Published: (2007)